NTLA
Intellia TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
NTLA vs peer average
85/100
NTLA vs. peer average (A vs. C)
Grade spread
A 1 · B 2 · C 3 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ANAB is the first available peer comparator.
Same-sector, similar-market-cap biotechnology reference; operating and clinical matches are loose, so valuation read-through is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NTLA
Intellia Therapeutics
ANAB
AnaptysBio
Grade
A
C
Momentum
34
32
Value
41
50
Sentiment
96
59
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs ANAB
NTLA / ANAB
Grade Position
Above peers
NTLA vs. peer average (A vs. C)
85/100
Momentum
34
NTLAValue
41
ANABSentiment
96
NTLARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NTLA
ANAB is the first peer returned for this comparison set.